{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:42:13Z","timestamp":1787146933135,"version":"build-2736575974"},"reference-count":10,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T00:00:00Z","timestamp":1420156800000},"content-version":"unspecified","delay-in-days":641,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:p>We conducted a randomized controlled trial in neonates with birth weight greater than or equal to 1,500 g that compared 1% aqueous chlorhexidine gluconate (CHG) with 10% povidone\u2013iodine (PI) as a topical antiseptic. We found 1% CHG to be more effective than 1% PI in reducing blood culture contamination rates, and no contact dermatitis was observed.<\/jats:p>","DOI":"10.1086\/669863","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T17:30:13Z","timestamp":1360863013000},"page":"430-432","source":"Crossref","is-referenced-by-count":37,"title":["A Randomized Controlled Trial of 1% Aqueous Chlorhexidine Gluconate Compared with 10% Povidone-Iodine for Topical Antiseptic in Neonates Effects on Blood Culture Contamination Rates"],"prefix":"10.1017","volume":"34","author":[{"given":"Pracha","family":"Nuntnarumit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nartsiri","family":"Sangsuksawang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2015,1,2]]},"reference":[{"key":"S0195941700032781_ref008","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2011.148"},{"key":"S0195941700032781_ref005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2010.10.015"},{"key":"S0195941700032781_ref004","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/0310057X0803600404","article-title":"Chlorhexidine-pharmacology and clinical applications","volume":"36","author":"Lim","year":"2008","journal-title":"Anaesth Intensive Care"},{"key":"S0195941700032781_ref010","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.054338"},{"key":"S0195941700032781_ref003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2004.tb00707.x"},{"key":"S0195941700032781_ref009","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199610000-00018"},{"key":"S0195941700032781_ref002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2008.03.001"},{"key":"S0195941700032781_ref001","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460030071031"},{"key":"S0195941700032781_ref006","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-11-200206040-00007"},{"key":"S0195941700032781_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2011.01.003"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0195941700032781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T19:01:41Z","timestamp":1556132501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0195941700032781\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0195941700032781"],"URL":"https:\/\/doi.org\/10.1086\/669863","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}